Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001867096-23-000151)

Filing Details

Accession Number:: 0001867096-23-000151
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-11-21 16:20:16
Reporting Period:: 2023-11-20

Accepted Time:: 2023-11-21 16:20:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1867096	Xeris Biopharma Holdings Inc.	XERS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1743658	Dawn Halkuff	C/O Xeris Biopharma Holdings, Inc. 1375 West Fulton Street, Suite 1300 Chicago IL 60607		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-11-20	5,410	$1.84	5,410	No	4	P	Indirect	By; DAWN HALKUFF REVOCABLE TRUST U/A DTD 08/25/2017

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By; DAWN HALKUFF REVOCABLE TRUST U/A DTD 08/25/2017

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	57,500	Direct

Footnotes

The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.